Treatment Persistence in Patients Cycling on Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors in Inflammatory Arthritis: A Retrospective Study

Introduction Biologic treatments including subcutaneous tumor necrosis factor-alpha inhibitors (SC-TNFis) have greatly improved disease management of rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS) (collectively inflammatory arthritis, IA). Nevertheless, some pat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	ADVANCES IN THERAPY 2022, Vol.39 (1), p.244-255
Hauptverfasser:	Dalén, Johan, Puenpatom, Amy, Luttropp, Karin, Svedbom, Axel, Black, Christopher M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antirheumatic Agents Arthritis, Psoriatic - drug therapy Arthritis, Rheumatoid - drug therapy Cardiology Endocrinology Etanercept - therapeutic use Female Humans Internal Medicine Male Medicine Medicine & Public Health Oncology Original Research Pharmacology/Toxicology Retrospective Studies Rheumatology Tumor Necrosis Factor-alpha - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!